Cargando…
Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer
BACKGROUND: There is an urgent need for better therapeutics in head and neck squamous cell cancer (HNSCC) to improve survival and decrease treatment morbidity. Recent advances in high-throughput drug screening techniques and next-generation sequencing have identified new therapeutic targets in other...
Autores principales: | Nichols, Anthony C, Black, Morgan, Yoo, John, Pinto, Nicole, Fernandes, Andrew, Haibe-Kains, Benjamin, Boutros, Paul C, Barrett, John W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258049/ https://www.ncbi.nlm.nih.gov/pubmed/25428177 http://dx.doi.org/10.1186/2050-6511-15-66 |
Ejemplares similares
-
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
por: Ghasemi, Farhad, et al.
Publicado: (2018) -
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
por: Ghasemi, Farhad, et al.
Publicado: (2017) -
Establishment of four head and neck squamous cell carcinoma cell lines: importance of reference DNA for accurate genomic characterisation
por: Patel, K B, et al.
Publicado: (2023) -
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
por: Ruicci, Kara M., et al.
Publicado: (2020) -
Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer
por: Parmar, Chintan, et al.
Publicado: (2015)